Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04883749
Title Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL (CLL-Frail)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors German CLL Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU | AUT

Facility Status City State Zip Country Details
Medizinische Universität Innsbruck Innsbruck 6020 Austria Details
Hanusch Krankenhaus Wien 1140 Austria Details
Onkologische Schwerpunktpraxis Kurfürstendamm Berlin 10707 Germany Details
Donau-Isar-Klinikum Deggendorf Hämatologie/Onkologie Deggendorf 94469 Germany Details
Oncoresearch Institut für klinische Studien GbR Erlangen 91052 Germany Details
Universitaetsklinikum Essen Essen 45147 Germany Details
Onkologische Kooperation Harz Goslar 38642 Germany Details
OncoResearch Lerchenfeld Hamburg 22081 Germany Details
MediProjekt GBR Hannover 30171 Germany Details
Universitaetsklinikum Schleswig-Holstein Campus Kiel Kiel 24105 Germany Details
Praxis fuer Haematologie und Onkologie Koblenz 56068 Germany Details
Universitätsklinik Köln Köln 50937 Germany Details
H.O.T Praxis Landshut Landshut 84036 Germany Details
Lübecker Onkologische Schwerpunktpraxis Lübeck 23562 Germany Details
Gemeinschaftspraxis Haematologie und Onkologie Magdeburg 39104 Germany Details
Gemeinschaftspraxis für Hämatologie und Onkologie Muenster 48153 Germany Details
Brüderkrankenhaus St. Josef Paderborn Paderborn 33098 Germany Details
Gemeinschaftspraxis für Hämatologie und Onkologie Ravensburg 88212 Germany Details
Universitaetsklinikum Ulm Ulm 89081 Germany Details
Hämatologisch Onkologische Schwerpunktpraxis Würzburg 97080 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field